multi-drug resistant
Showing 9976 - 10000 of >10,000
Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)
Recruiting
- Endometrial Neoplasms
- +3 more
- COM701 in combination with BMS-986207 and nivolumab.
-
Chicago, Illinois
- +8 more
Aug 8, 2022
Antimicrobial Prophylaxis, Asymptomatic Bacteriuria Trial in Warsaw (Anti-microbial prophylaxis for an endourological procedure
Unknown status
- Antimicrobial Prophylaxis
- Asymptomatic Bacteriuria
- Anti-microbial prophylaxis for an endourological procedure or ESWL
-
Warsaw, Mazowieckie, PolandMilitary Institue of Medicine
Feb 19, 2020
Schizophrenia, Schizoaffective Disorder, Bipolar Disorder Trial in Boston (transcranial electrical stimulation)
Completed
- Schizophrenia
- +2 more
- transcranial electrical stimulation
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Dec 16, 2022
Granulomatosis With Polyangiitis Trial in Canada, United States (5 mg Prednisone, 0 mg Prednisone)
Recruiting
- Granulomatosis With Polyangiitis
- 5 mg Prednisone
- 0 mg Prednisone
-
Kansas City, Kansas
- +8 more
Jan 25, 2022
Glioma Trial in Oxford (Fluorodopa PET tracer)
Recruiting
- Glioma
- Fluorodopa PET tracer
-
Oxford, Oxfordshire, United KingdomOxford University Hospitals NHS Foundation Trust
Jul 28, 2022
Seasonal Allergic Rhinitis Trial (desloratadine 5 mg, fexofenadine)
Completed
- Seasonal Allergic Rhinitis
- desloratadine 5 mg
- fexofenadine
- (no location specified)
Feb 7, 2022
Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis Trial (Desloratadine 5 mg (Clarinex), Cetirizine (Zyrtec))
Completed
- Seasonal Allergic Rhinitis
- Perennial Allergic Rhinitis
- Desloratadine 5 mg (Clarinex)
- Cetirizine (Zyrtec)
- (no location specified)
Feb 7, 2022
Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis Trial (Desloratadine 5 mg (Clarinex), Cetirizine (Zyrtec))
Completed
- Seasonal Allergic Rhinitis
- Perennial Allergic Rhinitis
- Desloratadine 5 mg (Clarinex)
- Cetirizine (Zyrtec)
- (no location specified)
Feb 7, 2022
Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis Trial (Desloratadine 5 mg (Clarinex), Cetirizine (Zyrtec))
Completed
- Seasonal Allergic Rhinitis
- Perennial Allergic Rhinitis
- Desloratadine 5 mg (Clarinex)
- Cetirizine (Zyrtec)
- (no location specified)
Feb 7, 2022
Seasonal Allergic Rhinitis Trial (desloratadine 5 mg, fexofenadine)
Completed
- Seasonal Allergic Rhinitis
- desloratadine 5 mg
- fexofenadine
- (no location specified)
Feb 7, 2022
Seasonal Allergic Rhinitis Trial (Desloratadine 5 mg, fexofenadine)
Completed
- Seasonal Allergic Rhinitis
- Desloratadine 5 mg
- fexofenadine
- (no location specified)
Feb 7, 2022
Marijuana Abuse Trial in New York (3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition,
Recruiting
- Marijuana Abuse
- 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition
- 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fasting condition
-
New York, New YorkSubstance Use Research Center
Jan 25, 2023
NSCLC (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL) Trial in Russian Federation (GNR-051)
Recruiting
- Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL)
- GNR-051
-
Kazan, Russian Federation
- +11 more
Sep 21, 2021
Prostate Cancer Trial run by the NCI (Enzalutamide Liquid, Enzalutamide Capsule)
Terminated
- Prostate Cancer
- Enzalutamide Liquid
- Enzalutamide Capsule
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 12, 2021
Mitochondrial Disease Trial in Leeds (KL1333, Flurbiprofen, Dextromethorphan)
Completed
- Mitochondrial Disease
- KL1333
- +7 more
-
Leeds, United KingdomVolunteer recruitment center Covance Leeds Covance Leeds
Oct 19, 2021
IBD Trial in Cincinnati (SDM Intervention)
Completed
- Inflammatory Bowel Diseases
- SDM Intervention
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 7, 2021
Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)
Active, not recruiting
- Homozygous Familial Hypercholesterolemia
-
Evanston, Illinois
- +11 more
Jul 13, 2022
Refractive Ametropia Trial (BL-3100-NBR03 multi-purpose solution, renu® Advanced Formula multi-purpose solution)
Not yet recruiting
- Refractive Ametropia
- BL-3100-NBR03 multi-purpose solution
- renu® Advanced Formula multi-purpose solution
- (no location specified)
Sep 30, 2022
Auditory Brainstem Response Trial in Nice (Dexmedetomidine Hydrochloride)
Active, not recruiting
- Auditory Brainstem Response
- Dexmedetomidine Hydrochloride
-
Nice, FranceHôpitaux pédiatriques de Nice CHU-Lenval
Sep 2, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Vincristine)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Vincristine
-
Birmingham, Alabama
- +20 more
Jan 23, 2023
Prostate Cancer Trial in Calgary (Tai Chi Prehabilitation, Usual care)
Recruiting
- Prostate Cancer
- Tai Chi Prehabilitation
- Usual care
-
Calgary, Alberta, CanadaProstate Cancer Centre
Jul 8, 2022
Special Drug Use Surveillance for Entresto Tablets
Active, not recruiting
- Chronic Heart Failure
-
Ichinomiya, Aichi, Japan
- +120 more
Aug 10, 2022
Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in
Recruiting
- Ann Arbor Stage II Follicular Lymphoma
- +5 more
- Ibrutinib
- +2 more
-
Fresno, California
- +2 more
Jan 24, 2023